DNTH
Dianthus Therapeutics Inc

1,241
Mkt Cap
$1.75B
Volume
1.57M
52W High
$41.15
52W Low
$13.37
PE Ratio
-11.70
DNTH Fundamentals
Price
$40.85
Prev Close
$35.50
Open
$34.56
50D MA
$35.94
Beta
0.95
Avg. Volume
548,890.09
EPS (Annual)
-$2.55
P/B
3.20
Rev/Employee
$79,935.90
Loading...
Loading...
Dianthus Therapeutics, Inc. is a clinical-stage biotechnology company. It designs and delivers novel, monoclonal antibodies with improved selectivity and potency over existing complement therapies. The company was founded on June 17, 2015 and is headquartered in New York, NY.
Sector:
Health Technology
Industry:
Biotechnology
Employees:
78

Frequently Asked Questions

What is Market Cap of Dianthus Therapeutics Inc?
What is the 52-week high for Dianthus Therapeutics Inc?
What is the 52-week low for Dianthus Therapeutics Inc?
What is Dianthus Therapeutics Inc stock price today?
What was Dianthus Therapeutics Inc stock price yesterday?
What is the PE ratio of Dianthus Therapeutics Inc?
What is the Price-to-Book ratio of Dianthus Therapeutics Inc?
What is the 50-day moving average of Dianthus Therapeutics Inc?
How many employess does Dianthus Therapeutics Inc has?

Latest DNTH News

View

Advertisement|Remove ads.

Advertisement|Remove ads.